Skip to content
Agree.net – Lifestyle
Author:
EverGlade Consulting
In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides
May 26, 2026
Ebola Global Health Emergency Needs a Broad-Spectrum Drug – NV-387 is a Strong Potential Candidate, Says NanoViricides
May 18, 2026
NanoViricides, Inc. Has Filed its Quarterly Report – NV-387 Advancing for Phase II
May 15, 2026
EVERGLADE HELPS LANDMARK BIO SECURE UP TO $18.3 MILLION IN ARPA-H FUNDING
April 16, 2026
EVERGLADE WELCOMES DR. PATRICK SIMS, EXPANDING ITS TECHNICAL AND FEDERAL EXPERTISE
April 8, 2026
←
Previous Page
1
2